Table 1.
Characteristic | Number (%) |
---|---|
Gender | |
Male | 405 (36) |
Female | 728 (64) |
WHO Staging | |
WHO Stage I | 305 (27) |
WHO Stage II | 421 (37) |
WHO Stage III | 279 (25) |
WHO Stage IV | 128 (11) |
Initial ART Regimen | |
AZT/3TC/EFV | 332 (29) |
AZT/3TC/NVP | 368 (33) |
D4T/3TC/EFV | 129 (11) |
D4T/3TC/NVP | 303 (27) |
TDF/3TC/NVP | 1 (0) |
Age | Median (IQR) |
years | 35 (30–41) |
CD4+ cell count | |
cells/mm3 | 153 (69–214) |